Breakthrough blood test detects relapse earlier and helps patients avoid unnecessary clinic visits with GI Expanded Access Program
SAN CARLOS, Calif., April 2, 2020 /PRNewswire/ — A new, peer-reviewed case study published in JCO Precision Oncology1 … […]
SOUTH SAN FRANCISCO, Calif., April 2, 2020 /PRNewswire/ — ORIC Pharmaceuticals, Inc., a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Christ… […]
– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating
PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]
– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating
PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]
– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating
PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]
– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating
PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]
– HDV Phase 3 D-LIVR Study Progressing; Impact to Timeline- Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating
PALO ALTO, Calif., April 1, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the deve… […]
SOUTH SAN FRANCISCO, Calif., April 1, 2020 /PRNewswire/ — Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) announced today that on March 31, 2020, the Compensation Committee of the Board of Directors approved, effective as of March 31, 2020, the grant… […]
The OptoSeq 3′ mRNA Library Kit allows users of Berkeley Lights’ platform to efficiently prepare cells of interest for genomic sequencing opening the door to directly link phenotype to genotype using a single system.
EMERYVILLE, Calif., March 31, 202… […]
The Synthetic Biology Leader Steps Out to Help Fight COVID-19
EMERYVILLE, Calif., March 31, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean … […]
© 2020 San Francisco Biotechnology Network
